Pro-inflammatory cytokines induce cell death, inflammatory responses, and endoplasmic reticulum stress in human iPSC-derived beta cells
Open accessAbstract
Background: Adult human pancreatic beta cells are the “gold standard” for studies on diabetes pathogenesis, but their use is limited by insufficient availability and variable quality. An important effort has recently taken place to differentiate beta cells from human induced pluripotent stem cells (iPSCs) and validate their use for diabetes research. We presently used a 7-stage protocol to generate beta cells from human iPSC and evaluated whether these cells are responsive to the pro-inflammatory cytokines (IFNγ, IL-1β, or IFNα) that play a role in type 1 diabetes. Methods: The iPSC-derived islet-like cell clusters contained 40–50% beta and 10–15% alpha cells and expressed the receptors for IFNγ, IL-1β, or IFNα. Cells were exposed to either IFNγ (1000 U/mL) + IL-1β (50 U/mL) or IFNα alone (2000 U/mL) for 24/48 h. Apoptosis was quantified using Hoechst/propidium iodide staining or the RealTime Glo Apoptosis Kit (Promega). After treatment, CXCL10 secretion was quantified by ELISA. The expression of multiples genes ( Ins , Gcg , Nkx2.2 , Nkx6.1 , Pdx1 , Mafa , BiP , Chop , Atf3 , CXCL10 , CXCL9 , CCL5 , and HLA-ABC ) was quantified by RT-qPCR. Phosphorylation state and total expression of STAT1/STAT2, as well as expression of PDL1 and of the ER chaperone BiP, were quantified by Western blotting. The co-localization of HLA-ABC or cleaved caspase-3 and Ins/Gcg expression was assessed by immunohistochemistry. The presence of HLA-ABC at the plasma membrane was measured by flow cytometry. Results: IFNγ + IL-1β and IFNα induced apoptosis of the cells after 48 h of exposure. Cleaved caspase-3 co-localized mostly but not exclusively with Ins+ cells. Exposure to IFNγ + IL-1β induced a pro-inflammatory phenotype, including increased CXCL10 , CXCL9 , and CCL5 expression; CXCL10 secretion; and HLA-ABC expression. HLA overexpression was confirmed at the protein level by Western blotting and flow cytometry. Exposure to IFNγ + IL-1β (but not IFNα) also induced beta cell dedifferentiation and endoplasmic reticulum stress (increase in BiP , Chop , and Atf3 mRNA expression). Phosphorylation of STAT1 was stimulated already after 1 h by IFNγ + IL-1β and IFNα, while phosphorylation of STAT2 was only activated by IFNα at 1–4 h. PDL1 expression was increased by both IFNγ + IL-1β and IFNα. Conclusions: Our data show that human iPSC-derived beta cells respond to pro-inflammatory cytokines IL-1β + IFNγ and IFNα, by activating the same pathogenic processes as adult human primary beta cells. These cells thus represent a valuable tool for future research on the pathogenesis of type 1 diabetes.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
While SC-islets appear to be generally more stress-resistant than isolated primary islets, they nevertheless respond to inflammatory cytokines with similar stress response pathways.
“Furthermore, while SC-islets appear to be generally more stress-resistant than isolated primary islets,136 they nevertheless respond to inflammatory cytokines with similar stress response pathways,137”
From Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes (2023) · cites this paper as [137]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
No citation lists for this paper
No citation lists for this paper yet — checked again daily.
References 30 · Cited by 107
Research works printed but not linked: 29
- [1]Eizirik DL Colli ML Ortis F The role of inflammation in insulitis and beta-cell loss in type 1 diabetes Nat Rev Endocrinol 2009 5 4 219 226 10.1038/nrendo.2009.21 19352320 · DOI · Paper page
- [2]Roep BO Atkinson M von Herrath M Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetes Nat Rev Immunol 2004 4 12 989 997 10.1038/nri1502 15573133 · DOI
- [3]Takahashi K Tanabe K Ohnuki M Narita M Ichisaka T Tomoda K Induction of pluripotent stem cells from adult human fibroblasts by defined factors Cell. 2007 131 5 861 872 10.1016/j.cell.2007.11.019 18035408 · DOI · Paper page
- [4]Takahashi K Yamanaka S Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell. 2006 126 4 663 676 10.1016/j.cell.2006.07.024 16904174 · DOI · Paper page
- [5]Yamanaka S Induced pluripotent stem cells: past, present, and future Cell Stem Cell 2012 10 6 678 684 10.1016/j.stem.2012.05.005 22704507 · DOI
- [6]Rezania A Bruin JE Arora P Rubin A Batushansky I Asadi A Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells Nat Biotechnol 2014 32 11 1121 1133 10.1038/nbt.3033 25211370 · DOI · Paper page
- [8]Saarimäki-Vire J Balboa D Russell MA Saarikettu J Kinnunen M Keskitalo S An activating STAT3 mutation causes neonatal diabetes through premature induction of pancreatic differentiation Cell Rep 2017 19 2 281 294 10.1016/j.celrep.2017.03.055 28402852 · DOI
- [9]Balboa D, Saarimäki-Vire J, Borshagovski D, Survila M, Lindholm P, Galli E, et al. Insulin mutations impair beta-cell development in a patient-derived iPSC model of neonatal diabetes. Elife. 2018;7. PMC6294552 30412052
- [10]Teo AK Windmueller R Johansson BB Dirice E Njolstad PR Tjora E Derivation of human induced pluripotent stem cells from patients with maturity onset diabetes of the young J Biol Chem 2013 288 8 5353 5356 10.1074/jbc.C112.428979 23306198 PMC3581399 · DOI
- [11]Shang L Hua H Foo K Martinez H Watanabe K Zimmer M β-cell dysfunction due to increased ER stress in a stem cell model of Wolfram syndrome Diabetes. 2014 63 3 923 933 10.2337/db13-0717 24227685 PMC3931392 · DOI
- [12]Cosentino C Toivonen S Diaz Villamil E Atta M Ravanat JL Demine S Pancreatic β-cell tRNA hypomethylation and fragmentation link TRMT10A deficiency with diabetes Nucleic Acids Res 2018 46 19 10302 10318 10.1093/nar/gky839 30247717 PMC6212784 · DOI
- [13]Millman JR Xie C Van Dervort A Gürtler M Pagliuca FW Melton DA Generation of stem cell-derived β-cells from patients with type 1 diabetes Nat Commun 2016 7 11463 10.1038/ncomms11463 27163171 PMC4866045 · DOI
- [14]Hosokawa Y, Toyoda T, Fukui K, Baden MY, Funato M, Kondo Y, et al. Insulin-producing cells derived from ‘induced pluripotent stem cells’ of patients with fulminant type 1 diabetes: vulnerability to cytokine insults and increased expression of apoptosis-related genes. J Diabetes Investig. 2017. PMC5934265 28796422
- [15]Cardozo AK Ortis F Storling J Feng YM Rasschaert J Tonnesen M Cytokines downregulate the sarcoendoplasmic reticulum pump Ca2+ ATPase 2b and deplete endoplasmic reticulum Ca2+, leading to induction of endoplasmic reticulum stress in pancreatic beta-cells Diabetes. 2005 54 2 452 461 10.2337/diabetes.54.2.452 15677503 · DOI
- [16]Brozzi F Nardelli TR Lopes M Millard I Barthson J Igoillo-Esteve M Cytokines induce endoplasmic reticulum stress in human, rat and mouse beta cells via different mechanisms Diabetologia. 2015 58 10 2307 2316 10.1007/s00125-015-3669-6 26099855 · DOI
- [17]Marroqui L Dos Santos RS Op de Beeck A Coomans de Brachène A Marselli L Marchetti P Interferon-α mediates human beta cell HLA class I overexpression, endoplasmic reticulum stress and apoptosis, three hallmarks of early human type 1 diabetes Diabetologia. 2017 60 4 656 667 10.1007/s00125-016-4201-3 28062922 · DOI · Paper page
- [18]Achuta VS Grym H Putkonen N Louhivuori V Kärkkäinen V Koistinaho J Metabotropic glutamate receptor 5 responses dictate differentiation of neural progenitors to NMDA-responsive cells in fragile X syndrome Dev Neurobiol 2017 77 4 438 453 10.1002/dneu.22419 27411166 · DOI
- [19]Juan-Mateu J Alvelos MI Turatsinze JV Villate O Lizarraga-Mollinedo E Grieco FA SRp55 regulates a splicing network that controls human pancreatic β-cell function and survival Diabetes. 2018 67 3 423 436 10.2337/db17-0736 29246973 PMC5828453 · DOI
- [20]Marchetti P Suleiman M Marselli L Organ donor pancreases for the study of human islet cell histology and pathophysiology: a precious and valuable resource Diabetologia. 2018 61 4 770 774 10.1007/s00125-018-4546-x 29354869 PMC6449064 · DOI
- [21]Grieco FA, Schiavo AA, Brozzi F, Juan-Mateu J, Bugliani M, Marchetti P, et al. The microRNAs miR-211-5p and miR-204-5p modulate ER stress in human beta cells. J Mol Endocrinol. 2019. PMC6938585 31277072
- [22]Colli ML Hill JLE Marroquí L Chaffey J Dos Santos RS Leete P PDL1 is expressed in the islets of people with type 1 diabetes and is up-regulated by interferons-α and-γ via IRF1 induction EBioMedicine. 2018 36 367 375 10.1016/j.ebiom.2018.09.040 30269996 PMC6197434 · DOI
- [23]Moore F Naamane N Colli ML Bouckenooghe T Ortis F Gurzov EN STAT1 is a master regulator of pancreatic {beta}-cell apoptosis and islet inflammation J Biol Chem 2011 286 2 929 941 10.1074/jbc.M110.162131 20980260 PMC3020778 · DOI
- [24]Koumenis C Naczki C Koritzinsky M Rastani S Diehl A Sonenberg N Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2alpha Mol Cell Biol 2002 22 21 7405 7416 10.1128/MCB.22.21.7405-7416.2002 12370288 PMC135664 · DOI
- [25]Coomans de Brachène A Dos Santos RS Marroqui L Colli ML Marselli L Mirmira RG IFN-α induces a preferential long-lasting expression of MHC class I in human pancreatic beta cells Diabetologia. 2018 61 3 636 640 10.1007/s00125-017-4536-4 29305625 PMC6241216 · DOI · Paper page
- [26]Eizirik DL Sammeth M Bouckenooghe T Bottu G Sisino G Igoillo-Esteve M The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines PLoS Genet 2012 8 3 e1002552 10.1371/journal.pgen.1002552 22412385 PMC3297576 · DOI · Paper page
- [27]Stene LC Gale EA The prenatal environment and type 1 diabetes Diabetologia. 2013 56 9 1888 1897 10.1007/s00125-013-2929-6 23657800 · DOI
- [28]Culina S Gupta N Boisgard R Afonso G Gagnerault MC Dimitrov J Materno-fetal transfer of preproinsulin through the neonatal Fc receptor prevents autoimmune diabetes Diabetes. 2015 64 10 3532 3542 10.2337/db15-0024 25918233 · DOI
- [29]Marroqui L Dos Santos R Fløyel T Grieco F Santin I Op de Beeck A TYK2, a candidate gene for type 1 diabetes, modulates apoptosis and the innate immune response in human pancreatic β-cells Diabetes 2015 64 11 3808 3817 10.2337/db15-0362 26239055 · DOI
- [30]Moore F Colli ML Cnop M Esteve MI Cardozo AK Cunha DA PTPN2, a candidate gene for type 1 diabetes, modulates interferon-gamma-induced pancreatic beta-cell apoptosis Diabetes. 2009 58 6 1283 1291 10.2337/db08-1510 19336676 PMC2682688 · DOI
- Authors
- Demine, S., Schiavo, A. A., Marín-Cañas, S., Marchetti, P., Cnop, M., & Eizirik, D. L.
- Affiliations
- Université Libre de Bruxelles (BE)
- University of Pisa (IT)
- Corresponding author
- Demine, Stéphane
- Venue
- Stem Cell Research & Therapy
- Published
- 2020-01-03
- Volume
- 11
- Issue
- 1
- Pages
- 7-7
- ISSN
- 1757-6512 (ISSN-L)
- PMC
- PMC6942385
- OpenAlex
- W2999494623
- Cited by
- 107
- References
- 30
- Citations by year
- 2026: 13 · 2025: 19 · 2024: 11 · 2023: 18 · 2022: 18 · 2021: 21 · 2020: 6
- FWCI
- 14.39
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Stem Cell Research & Therapy (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion, cc-by)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Welbio (WELBIO-CR-2019C-04)
- Innoviris (BRIDGE DiaType)
- INNODIA (115797)
- Juvenile Diabetes Research Foundation United States of America (-)
- Leona M. and Harry B. Helmsley Charitable Trust (-)
- Horizon 2020 Framework Programme (667191)
- European Union (Project T2D Systems)
- Topics
- Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Keywords
- inflammatory cytokines, interferon-gamma, IL-1β, interferon-alpha, beta-cell apoptosis, endoplasmic reticulum stress, type 1 diabetes, islet-like cell clusters, CXCL10, BiP, cleaved caspase-3
- MeSH terms
- Homeobox Protein Nkx-2.2, Humans, Nuclear Proteins, Transcription Factors, Cytokines, Cell Death, Homeodomain Proteins, Insulin-Secreting Cells, Induced Pluripotent Stem Cells, Endoplasmic Reticulum Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review